Novo Nordisk's board had a merger agreed and the bankers in the room. The nonprofit foundation that governs the company asked one question: what problem does this solve? Eric Ries on why that "no" kept the R&D intact that went on to produce its GLP-1 breakthrough.
Historical example only; not a view on any company's securities.
Full episode: https://www.theinvestorrelationspodcast.com/learn-to-become-incorruptible-with-eric-ries/
Apple: https://podcasts.apple.com/us/podcast/learn-to-become-incorruptible-with-eric-ries/id1791628629?i=1000769626531&uo=4
Spotify: https://open.spotify.com/episode/7MJT2ENfy2Sty9ErekQeJA
Guest: Eric Ries, author of The Lean Startup and Incorruptible, founder of the Long-Term Stock Exchange — https://www.linkedin.com/in/eries/
Host: Joshua Wilson — https://www.linkedin.com/in/joshuabrucewilson/
Educational content only. Nothing here is investment, legal or tax advice, or a solicitation.
Full episode on YouTube: https://youtu.be/YjyK__q1Kvg
#InvestorRelations #CorporateGovernance #MergersAndAcquisitions #LongTermThinking #EricRies #TheInvestorRelationsPodcast
A One Iron Network production: Executive Producer Joshua Wilson
